Showing results (101-110 of 4,808) with videos related to
Sort By:
Pageof 481
American Journal of Hematology|September 25, 2024
Measurable residual disease monitoring in AML: Prospects for therapeutic decision-making and new drug developmentNicholas J Short, Richard DillonClinics in Podiatric Medicine and Surgery|June 4, 2017
Management of Osteomyelitis and Bone Loss in the Diabetic Charcot Foot and AnkleDaniel J Short, Thomas ZgonisCurrent Oncology Reports|February 17, 2017
Minimal Residual Disease in Acute Lymphoblastic Leukemia: How to Recognize and Treat ItNicholas J Short, Elias JabbourClinical Lymphoma, Myeloma & Leukemia|August 14, 2016
Acute Myeloid Leukemia: Past, Present, and Prospects for the FutureNicholas J Short, Farhad RavandiThe Lancet. Haematology|June 30, 2022
Choosing between intensive and less intensive front-line treatment approaches for older patients with newly diagnosed acute myeloid leukaemiaNicholas J Short, Hagop KantarjianExpert Review of Hematology|May 10, 2016
The safety and efficacy of vosaroxin in patients with first relapsed or refractory acute myeloid leukemia - a critical reviewNicholas J Short, Farhad RavandiAmerican Journal of Hematology|July 24, 2022
Hypomethylating agents for the treatment of myelodysplastic syndromes and acute myeloid leukemia: Past discoveries and future directionsNicholas J Short, Hagop KantarjianClinics in Podiatric Medicine and Surgery|November 21, 2016
Medical Imaging in Differentiating the Diabetic Charcot Foot from OsteomyelitisDaniel J Short, Thomas ZgonisThe Journal of Infectious Diseases|January 1, 1989
Monoclonal antibodies to Pneumocystis carinii: identification of specific antigens and characterization of antigenic differences between rat and human isolatesJ A Kovacs, J L Halpern, B Lundgren, et al.The American Journal of Medicine|May 1, 1985
Erysipelothrix rhusiopathiae bacteremia presenting as septic shockF P Ognibene, R E Cunnion, V Gill, et al.Pageof 481